SCID, X-Linked: Clinical Trials

1 trial for SCID, X-Linked, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow SCID, X-Linked: new trials by email Literature Review of SCID, X-Linked trials Research Report on SCID, X-Linked

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection
Direct intravenous injection of ivlv-X1 lentiviral vector - SCID, X-Linked
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute102027-06-302026-08-27

Narrower conditions

X-Linked Combined Immunodeficiency Diseases (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infant, Newborn, Diseases (1)  ·  Primary Immunodeficiency Diseases (1)  ·  Severe Combined Immunodeficiency (1)

Sponsors

Shenzhen Geno-Immune Medical Institute (1)

Countries

China (1)

Top investigators

Lung-Ji Chang, Ph.D (1)